Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma

oleh: Cesar A. Virgen, MD, PhD, Tuyet A. Nguyen, MD, Cosimo Di Raimondo, MD, Arya Amini, MD, Kim A. Margolin, MD, Vishwas Parekh, MD, Farah R. Abdulla, MD, Badri Modi, MD

Format: Article
Diterbitkan: Elsevier 2020-03-01

Deskripsi

Subjek

bullous pemphigoid; cemiplimab; programmed death ligand 1; programmed cell death protein 1; rituximab; squamous cell carcinoma